AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2012

May 9, 2012

32870_dirs_2012-05-09_744f74c6-f202-4851-b460-7e8b127c8f3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-05-08

Reporting Person: Intervac, L.L.C. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-08	Common Stock	J	45647	—	Disposed	5591147	Direct
2012-05-08	Common Stock	J	45647	—	Disposed	5545500	Direct
2012-05-08	Common Stock	J	45647	—	Disposed	5499853	Direct
2012-05-08	Common Stock	J	779951	—	Disposed	4719902	Direct

Footnotes

F1: The disposition reported on this line occurred as a result of a redemption by Intervac, L.L.C. of membership interests of certain members of Intervac, L.L.C. There was no sale of securities by Intervac, L.L.C.